Form 4 for MEDP Medpace Holdings, Inc.

Accepted 2021-07-14 00:00:00 ET · period of report 2021-07-12 · accession 0001567619-21-013376 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-07-14	2021-07-12+	MEDP	Medpace Investors, LLC	10%	S - Sale	$183.08	-23.6K	6.19M	-0.4%	-$4.32M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-07-13	S	D	13,050	$182.96	6,176,138	D	—	—	(F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.325 to $184.59. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
2	Common	Common Stock	2021-07-12	S	D	10,540	$183.22	6,189,188	D	—	—	(F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.715 to $184.76. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.